-
strategic dissemination, ultimately aiming for widespread adoption and commercial success. If you are still awaiting your PhD to be awarded you will be appointed at Grade 6, spine point 30. Upon written
-
31 August 2027. You should have obtained a PhD, or passed PhD viva, in Materials Science, Chemistry, Mechanical Engineering, or Chemical Engineering. If you are still awaiting your PhD to be awarded
-
and Medical Sciences and will work closely with a large, interdisciplinary team of academic researchers and clinical collaborators. You should have a PhD (or be about to obtain) in areas relevant
-
presentations to stakeholders where appropriate. ¿ To identify and engage in personal development opportunities to support your career development. You should have a PhD in nutrition, public health
-
. Experience with CRISPR gene editing, microinjection and/or animal work would also be an advantage. Preferred start date October 2025 - the post is available until September 2029. You should have a PhD or
-
an elephant or a tumour. Here, we propose to understand the relevance of this mechanism during tumorigenesis in collaboration with the Clatterbridge Cancer Centre. You should have a PhD (or about to
-
computer codes to solve some of the daily research problems and have experience with high performance computing. You should have a PhD in Chemistry, Physics or Materials Science with a proven research track
-
We are recruiting two postdoctoral research associates with expertise in mass spectrometry-based protein analysis. You will be embedded in a larger team with another PDRA and a PhD, fully funded by
-
to communicate effectively with key stakeholders are essential. You will have a PhD (or will be close to submitting/defending your thesis) in experimental nuclear or particle physics or in a discipline relevant
-
research. The post is funded for four years as part of a four-year project grant from The Leverhulme Trust. You will have a PhD (awarded or soon to be awarded) in comparative vertebrate anatomy and/or